2m 2m 2m 2m 2m 2m 2m
BIOFRONTERA (BFRI)
NASDAQ
$1.00+$0.01 (+1.37%)
Price as of Jun 03, 2026 7:56 PM EDT- $11.3MMarket Cap
- 56.48%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BIOFRONTERA (BFRI)
$1.00+$0.01 (+1.37%)
BFRI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.99 | ||
Change | -$0.04 (-4.32%) | ||
Open | $1.04 | ||
High | $1.04 | ||
Low | $0.96 | ||
Previous Close | $1.03 | ||
Volume | 144,645 | ||
30-Day Average Volume | 262,456 | ||
1-Week Change | 14.86% | ||
1-Month Change | -8.75% | ||
1-Year Change | 56.48% | ||
3-Year Change | -89.71% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.8M | ||
Total Assets | $24.8M | ||
Market Cap | $11.3M | ||
Enterprise Value | $9.7M | ||
Period: QTR TTM FY | |||
Revenue | $10.1M | ||
Net Income | N/A | ||
Free Cash Flow | -$75,000.00 | ||
EBIT | $125,000.00 | ||
EBITDA | $180,000.00 | ||
Net Working Capital | $2.2M | ||
EPS | -$0.41 | ||
Enterprise Value/EBITDA | 54 | ||
Enterprise Value/Revenue | 1 | ||
P/B | N/A | ||
P/E | -2 | ||
PEG | N/A | ||
Price/Free Cash Flow | -151 | ||
Price/Operating Cash Flow | -162 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 07/05/2023 | ||
Earnings & Revenue